Thus, suppression of TG biosynthesis by selective inhibition of DGAT2 improves steatohepatitis and insulin sensitivity, but at the same time exacerbates liver damage in a methionine and choline deficient (MCD) mouse model of NASH 6. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.